Drug distribution in the body is intricately regulated by various physiological barriers that control the passage of substances. These include the capillary endothelial barrier, the blood-brain, blood-cerebrospinal fluid, blood-placental, and blood-testis barriers.

The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.

The blood-brain barrier (BBB) is a specialized, semi-permeable cell membrane that separates the circulating blood from the brain's extracellular fluid. This barrier consists of tightly packed endothelial cells, astrocytic end-feet, and a basement membrane, creating a highly selective interface. The BBB allows only certain substances, such as small lipophilic molecules and essential nutrients, to pass through while restricting the entry of many drugs, particularly water-soluble ones like dopamine. However, in the case of neurological disorders such as Parkinson's disease, levodopa, a drug that can cross the BBB, is administered. Inside the central nervous system (CNS), levodopa is converted into dopamine, mitigating the symptoms of Parkinson's disease.

The blood-cerebrospinal fluid (CSF) barrier, which separates the blood from the CSF surrounding the brain and spinal cord, permits the passage of highly lipophilic drugs. Although drugs can enter the CSF, they face challenges in maintaining high concentrations due to continuous removal by the CSF's bulk flow. Interestingly, certain drugs, like sulfamethoxazole, can achieve higher concentrations in the CSF than in the cerebral region.

The blood-placental barrier during pregnancy allows the passage of moderate to highly lipid-soluble drugs with a molecular weight below 1000 Da. Substances like barbiturates, steroids, and anticonvulsants can cross this barrier via simple diffusion, influencing fetal exposure to these drugs.

In addition to these barriers, the blood-testis barrier, formed by tight junctions between Sertoli cells in the testes, plays a vital role. It restricts the passage of drugs to spermatocytes, protecting developing sperm cells. Efflux pumps further reinforce this barrier by preventing the entry of cytotoxic drugs like doxorubicin, safeguarding the delicate process of spermatogenesis.

These physiological barriers act as complex gatekeepers, regulating the distribution of drugs within the body, ensuring targeted drug delivery, and preserving the integrity of vital organs and processes. Understanding these barriers is essential for developing effective drug therapies and minimizing potential side effects.

From Chapter 4:

article

Now Playing

4.3 : Factors Affecting Drug Distribution: Physiological Barriers

Pharmacokinetics: Drug Distribution and Protein Binding

85 Views

article

4.1 : Drug Distribution: Overview

Pharmacokinetics: Drug Distribution and Protein Binding

76 Views

article

4.2 : Factors Affecting Drug Distribution: Tissue Permeability

Pharmacokinetics: Drug Distribution and Protein Binding

64 Views

article

4.4 : Factors Affecting Drug Distribution: Organ Perfusion Rate

Pharmacokinetics: Drug Distribution and Protein Binding

40 Views

article

4.5 : Factors Affecting Drug Distribution: Miscellaneous Factors

Pharmacokinetics: Drug Distribution and Protein Binding

91 Views

article

4.6 : Volume of Distribution

Pharmacokinetics: Drug Distribution and Protein Binding

42 Views

article

4.7 : Protein-Drug Binding: Mechanism and Kinetics

Pharmacokinetics: Drug Distribution and Protein Binding

92 Views

article

4.8 : Drug Binding to Blood Components

Pharmacokinetics: Drug Distribution and Protein Binding

31 Views

article

4.9 : Tissue-Drug Binding: Localization of Drugs and its Significance

Pharmacokinetics: Drug Distribution and Protein Binding

28 Views

article

4.10 : Protein-Drug Binding: Determination Methods

Pharmacokinetics: Drug Distribution and Protein Binding

63 Views

article

4.11 : Factors Affecting Protein-Drug Binding: Drug-Related Factors

Pharmacokinetics: Drug Distribution and Protein Binding

40 Views

article

4.12 : Factors Affecting Protein-Drug Binding: Protein-Related Factors

Pharmacokinetics: Drug Distribution and Protein Binding

70 Views

article

4.13 : Factors Affecting Protein-Drug Binding: Drug Interactions

Pharmacokinetics: Drug Distribution and Protein Binding

30 Views

article

4.14 : Factors Affecting Protein-Drug Binding: Patient-Related Factors

Pharmacokinetics: Drug Distribution and Protein Binding

24 Views

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved